Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer

被引：2

作者：

Koochekpour, Shahriar ^{[1
,2
]}

机构：

[1] Roswell Pk Canc Inst, Ctr Genet & Pharmacol, Dept Canc Genet, Buffalo, NY 14263 USA

[2] Roswell Pk Canc Inst, Ctr Genet & Pharmacol, Dept Urol, Buffalo, NY 14263 USA

来源：

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2014年 / 10卷 / 06期

关键词：

CASTRATION; LANDSCAPE;

D O I：

10.7150/ijbs.9576

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：652 / 653

页数：2

共 50 条

[41] Hormonal Therapy for Prostate Cancer: Toward Further Unraveling of Androgen Receptor Function [J].

Sharifi, Nima .

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (10) :1046-1051

[42] Androgen Receptor Rearrangement and Splicing Variants in Resistance to Endocrine Therapies in Prostate Cancer [J].

Ho, Yeung ;

Dehm, Scott M. .

ENDOCRINOLOGY, 2017, 158 (06) :1533-1542

[43] Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer [J].

Ravindranathan, Preethi ;

Lee, Tae-Kyung ;

Yang, Lin ;

Centenera, Margaret M. ;

Butler, Lisa ;

Tilley, Wayne D. ;

Hsieh, Jer-Tsong ;

Ahn, Jung-Mo ;

Raj, Ganesh V. .

NATURE COMMUNICATIONS, 2013, 4

[44] TET2 binds the androgen receptor and loss is associated with prostate cancer [J].

Nickerson, M. L. ;

Das, S. ;

Im, K. M. ;

Turan, S. ;

Berndt, S. I. ;

Li, H. ;

Lou, H. ;

Brodie, S. A. ;

Billaud, J. N. ;

Zhang, T. ;

Bouk, A. J. ;

Butcher, D. ;

Wang, Z. ;

Sun, L. ;

Misner, K. ;

Tan, W. ;

Esnakula, A. ;

Esposito, D. ;

Huang, W. Y. ;

Hoover, R. N. ;

Tucker, M. A. ;

Keller, J. R. ;

Boland, J. ;

Brown, K. ;

Anderson, S. K. ;

Moore, L. E. ;

Isaacs, W. B. ;

Chanock, S. J. ;

Yeager, M. ;

Dean, M. ;

Andresson, T. .

ONCOGENE, 2017, 36 (15) :2172-2183

[45] Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells [J].

Lee, Eugine ;

Ha, Susan ;

Logan, Susan K. .

PLOS ONE, 2015, 10 (10)

[46] Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens [J].

Crawford, E. David ;

Schellhammer, Paul F. ;

McLeod, David G. ;

Moul, Judd W. ;

Higano, Celestia S. ;

Shore, Neal ;

Denis, Louis ;

Iversen, Peter ;

Eisenberger, Mario A. ;

Labrie, Fernand .

JOURNAL OF UROLOGY, 2018, 200 (05) :956-966

[47] Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer [J].

Mirkheshti, Nooshin ;

Park, Sulgi ;

Jiang, Shoulei ;

Cropper, Jodie ;

Werner, Sherry L. ;

Song, Chung S. ;

Chatterjee, Bandana .

ONCOTARGET, 2016, 7 (38) :62240-62254

[48] Current and potential targets for drug design in the androgen receptor pathway for prostate cancer [J].

Guddati, Achuta Kumar .

EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (06) :489-496

[49] New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway [J].

Attard, Gerhardt ;

Richards, Juliet ;

de Bono, Johann S. .

CLINICAL CANCER RESEARCH, 2011, 17 (07) :1649-1657

[50] Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1 [J].

Cai, Changmeng ;

He, Housheng Hansen ;

Chen, Sen ;

Coleman, Ilsa ;

Wang, Hongyun ;

Fang, Zi ;

Chen, Shaoyong ;

Nelson, Peter S. ;

Liu, X. Shirley ;

Brown, Myles ;

Balk, Steven P. .

CANCER CELL, 2011, 20 (04) :457-471

← 1 2 3 4 5 →